The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Network model of survival signaling in large granular lymphocyte leukemia
Open accessAbstract
T cell large granular lymphocyte (T-LGL) leukemia features a clonal expansion of antigen-primed, competent, cytotoxic T lymphocytes (CTL). To systematically understand signaling components that determine the survival of CTL in T-LGL leukemia, we constructed a T-LGL survival signaling network by integrating the signaling pathways involved in normal CTL activation and the known deregulations of survival signaling in leukemic T-LGL. This network was subsequently translated into a predictive, discrete, dynamic model. Our model suggests that the persistence of IL-15 and PDGF is sufficient to reproduce all known deregulations in leukemic T-LGL. This finding leads to the following predictions: ( i ) Inhibiting PDGF signaling induces apoptosis in leukemic T-LGL. ( ii ) Sphingosine kinase 1 and NFκB are essential for the long-term survival of CTL in T-LGL leukemia. ( iii ) NFκB functions downstream of PI3K and prevents apoptosis through maintaining the expression of myeloid cell leukemia sequence 1. ( iv ) T box expressed in T cells (T-bet) should be constitutively activated concurrently with NFκB activation to reproduce the leukemic T-LGL phenotype. We validated these predictions experimentally. Our study provides a model describing the signaling network involved in maintaining the long-term survival of competent CTL in humans. The model will be useful in identifying potential therapeutic targets for T-LGL leukemia and generating long-term competent CTL necessary for tumor and cancer vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
Heldin, C.-H., & Westermark, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1283 · Cited by 2,496
Phenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
Intlekofer, A. M., Takemoto, N., Wherry, E. J., Longworth, S. A., Northrup, J. T., Palanivel, V. R., Mullen, A. C., Gasink, C. R., Kaech, S. M., Miller, J. D., et al. (2005) · Nature Immunology · doi:10.1038/ni1268 · Cited by 1,266
Hayden, M. S., West, A. P., & Ghosh, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209943 · Cited by 1,178
Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, T., & Gerritsen, M. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21096 · Cited by 1,053
Circuitry of nuclear factor κB signaling
Hoffmann, A., & Baltimore, D. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00375.x · Cited by 907
Epling-Burnette, P. K., Liu, J. H., Catlett-Falcone, R., Turkson, J., Oshiro, M., Kothapalli, R., Li, Y., Wang, J.-M., Yang-Yen, H.-F., Karras, J., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9940 · Cited by 633
Self-citationDiscovery and evaluation of inhibitors of human sphingosine kinase.
French, K. J., Schrecengost, R. S., Lee, B. D., Zhuang, Y., Smith, S. N., Eberly, J. L., Yun, J. K., & Smith, C. D. (2003) · PubMed · Cited by 599
Self-citationCD8 + T‐cell memory in tumor immunology and immunotherapy
Klebanoff, C. A., Gattinoni, L., & Restifo, N. P. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00391.x · Cited by 511
Li, S., Assmann, S. M., & Albert, R. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040312 · Cited by 418
Self-citationFehniger, T. A., Suzuki, K., Ponnappan, A., VanDeusen, J. B., Cooper, M. A., Florea, S. M., Freud, A. G., Robinson, M. L., Durbin, J., & Caligiuri, M. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.219 · Cited by 373
Robustness and fragility of Boolean models for genetic regulatory networks
Chaves, M., Albert, R., & Sontag, E. D. (2005) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2005.01.023 · Cited by 342
Self-citationAntitumor Activity of Sphingosine Kinase Inhibitors
French, K. J., Upson, J. J., Keller, S. N., Zhuang, Y., Yun, J. K., & Smith, C. D. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101345 · Cited by 242
Self-citationThe role of CD95 in the regulation of peripheral T‐cell apoptosis
Krueger, A., Fas, S. C., Baumann, S., & Krammer, P. H. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00047.x · Cited by 204
Liu, K., Catalfamo, M., Li, Y., Henkart, P. A., & Weng, N.-P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092675799 · Cited by 199
Silencing T-bet Defines a Critical Role in the Differentiation of Autoreactive T Lymphocytes
Lovett-Racke, A. E., Rocchini, A. E., Choy, J., Northrop, S. C., Hussain, R. Z., Ratts, R. B., Sikder, D., & Racke, M. K. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.010 · Cited by 183
Dysregulation of CD95/CD95 Ligand-Apoptotic Pathway in CD3+ Large Granular Lymphocyte Leukemia
Lamy, T., Liu, J. H., Landowski, T. H., Dalton, W. S., & Loughran, T. P. (1998) · Blood · doi:10.1182/blood.v92.12.4771 · Cited by 153
Self-citationT-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia
Solomou, E. E., Keyvanfar, K., & Young, N. S. (2006) · Blood · doi:10.1182/blood-2005-10-4201 · Cited by 151
Zambello, R., Facco, M., Trentin, L., Sancetta, R., Tassinari, C., Perin, A., Milani, A. M., Pizzolo, G., Rodeghiero, F., Agostini, C., et al. (1997) · Blood · doi:10.1182/blood.v89.1.201 · Cited by 122
Hsu, C., Jones, S. A., Cohen, C. J., Zheng, Z., Kerstann, K. W., Zhou, J., Robbins, P. F., Peng, P. D., Shen, X., Gomes, T. J., et al. (2007) · Blood · doi:10.1182/blood-2006-06-029173 · Cited by 112
Włodarski, M. W., O’Keefe, C. L., Howe, E. C., Risitano, A. M., Rodriguez, A., Warshawsky, I., Loughran, T. P., & Maciejewski, J. P. (2005) · Blood · doi:10.1182/blood-2004-10-4045 · Cited by 110
Self-citationShah, M. V., Zhang, R., Irby, R., Kothapalli, R., Liu, X., Arrington, T., Frank, B. C., Lee, N. H., & Loughran, T. P. (2008) · Blood · doi:10.1182/blood-2007-11-121871 · Cited by 109
Self-citationT-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes
Juedes, A. E., Rodrigo, E., Togher, L. M., Glimcher, L. H., & von Herrath, M. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031873 · Cited by 94
Yang, J., Epling‐Burnette, P. K., Painter, J. S., Zou, J., Bai, F., Sheng, W., & Loughran, T. P. (2007) · Blood · doi:10.1182/blood-2007-06-093823 · Cited by 92
Self-citationPlatelet-derived growth factor is a potent biologic response modifier of T cells.
Daynes, R. A., Dowell, T., & Araneo, B. A. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.6.1323 · Cited by 92
IL‐15 Is a Growth Factor and an Activator of CD8 Memory T Cells
Weng, N., Liu, K., Catálfamo, M., Li, Y., & Henkart, P. A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb05940.x · Cited by 87
T‐bet is essential for the progression of experimental autoimmune encephalomyelitis
Nath, N., Prasad, R. C., Giri, S., Singh, A. K., & Singh, I. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02385.x · Cited by 84
Schade, A. E., Powers, J. J., Włodarski, M. W., & Maciejewski, J. P. (2006) · Blood · doi:10.1182/blood-2005-08-3076 · Cited by 81
Epling‐Burnette, P. K., Bai, F., Wei, S., Chaurasia, P., Painter, J. S., Olashaw, N., Hamilton, A. D., Sebti, S. M., Djeu, J. Y., & Loughran, T. P. (2004) · Oncogene · doi:10.1038/sj.onc.1208122 · Cited by 79
Self-citationChristensen, C., Thakar, J., & Albert, R. (2007) · IET Systems Biology · doi:10.1049/iet-syb:20060071 · Cited by 60
Self-citationA Novel Method for Signal Transduction Network Inference from Indirect Experimental Evidence
Albert, R., DasGupta, B., Dondi, R., Kachalo, S., Sontag, E. D., Zelikovsky, A., & Westbrooks, K. (2007) · Journal of Computational Biology · doi:10.1089/cmb.2007.0015 · Cited by 59
Self-citationKothapalli, R., Nyland, S. B., Kusmartseva, I., et al. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.2.529 · Cited by 51
Self-citationKothapalli, R., Bailey, R. D., Kusmartseva, I., Mane, S., Epling‐Burnette, P. K., & Loughran, T. P. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.1.33 · Cited by 50
Self-citationFuchs, A. F. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb07554.x · Cited by 24
Loughran, T. J., Aprile, J., & Ruscetti, F. (1990) · Blood · doi:10.1182/blood.v75.4.935.935 · Cited by 16
Self-citation
Cited by
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
Koskela, H. L. M., Eldfors, S., Ellonen, P., van Adrichem, A. J., Kuusanmäki, H., Andersson, E. I., Lagström, S., Clemente, M. J., Olson, T., Jalkanen, S. E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114885 · Cited by 777
Self-citationBoolean modeling in systems biology: an overview of methodology and applications
Wang, R.-S., Saadatpour, A., & Albert, R. (2012) · Physical Biology · doi:10.1088/1478-3975/9/5/055001 · Cited by 463
Self-citationRealistic control of network dynamics
Cornelius, S. P., Kath, W. L., & Motter, A. E. (2013) · Nature Communications · doi:10.1038/ncomms2939 · Cited by 352
Saez‐Rodriguez, J., Alexopoulos, L. G., Epperlein, J., Samaga, R., Lauffenburger, D. A., Klamt, S., & Sorger, P. K. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.87 · Cited by 351
Logic-Based Models for the Analysis of Cell Signaling Networks
Morris, M. K., Saez-Rodriguez, J., Sorger, P. K., & Lauffenburger, D. A. (2010) · Biochemistry · doi:10.1021/bi902202q · Cited by 332
Metadata
- Authors
- Zhang, R., Shah, M. V., Yang, J., Nyland, S. B., Liu, X., Yun, J. K., Albert, R., & Loughran, T. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-10-21
- Volume
- 105
- Issue
- 42
- Pages
- 16308-16313
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2151852639
- Cited by
- 375
- References
- 36
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.